Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEURAMINIDASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sidwell, RW; Smee, DF; Bailey, KW; Burger, RA
      Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Fleming, DM
      Managing influenza: Amantadine, rimantadine and beyond

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    3. Kandel, R; Hartshorn, KL
      Prophylaxis and treatment of influenza virus infection

      BIODRUGS
    4. Ehlers, M; Silagy, C; Fleming, D; Freeman, D
      New approaches for managing influenza in primary care

      CLINICAL DRUG INVESTIGATION
    5. Cram, P; Blitz, SG; Monto, A; Fendrick, AM
      Influenza - Cost of illness and considerations in the economic evaluation of new and emerging therapies

      PHARMACOECONOMICS
    6. Alagiriswami, A; Cheeseman, SH
      Influenza and HIV: Case report and review of potential interactions

      AIDS PATIENT CARE AND STDS
    7. Niederman, MS; Mandell, LA; Anzueto, A; Bass, JB; Broughton, WA; Campbell, GD; Dean, N; File, T; Fine, MJ; Gross, PA; Martinez, F; Marrie, TJ; Plouffe, JF; Ramirez, J; Sarosi, GA; Torres, A; Wilson, R; Yu, VL
      Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    8. McNicholl, IR; McNicholl, JJ
      Neuraminidase inhibitors: Zanamivir and oseltamivir

      ANNALS OF PHARMACOTHERAPY
    9. Muennig, PA; Khan, K
      Cost-effectiveness of vaccination versus treatment of influenza in healthyadolescents and adults

      CLINICAL INFECTIOUS DISEASES
    10. Poehling, KA; Edwards, KM
      Prevention, diagnosis, and treatment of influenza: current and future options

      CURRENT OPINION IN PEDIATRICS
    11. van Elden, LJR; van Essen, GA; Boucher, CAB; van Loon, AM; Nijhuis, M; Schipper, P; Verheij, TJM; Hoepelman, IM
      Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice

      BRITISH JOURNAL OF GENERAL PRACTICE
    12. Fleming, DM; Zambon, M
      Update on influenza and other viral pneumonias

      CURRENT OPINION IN INFECTIOUS DISEASES
    13. Stephenson, I; Nicholson, KG
      Influenza: vaccination and treatment

      EUROPEAN RESPIRATORY JOURNAL
    14. Whitley, RJ; Hayden, FG; Reisinger, KS; Young, N; Dutkowski, R; Ipe, D; Mills, RG; Ward, P
      Oral oseltamivir treatment of influenza in children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    15. Longworth, DL
      Microbial drug resistance and the roles of the new antibiotics

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    16. Arora, A; Magee, L; Peck, J; Singer, J
      Antiviral therapeutics for the pediatric population

      PEDIATRIC EMERGENCY CARE
    17. Szucs, T; Behrens, M; Volmer, T
      Costs of influenza in Germany 1996 - a cost-of-illness study

      MEDIZINISCHE KLINIK
    18. Dharnidharka, VR; Harmon, WE
      Management of pediatric postrenal transplantation infections

      SEMINARS IN NEPHROLOGY
    19. Cox, RJ; Mykkeltvedt, E; Sjursen, H; Haaheim, LR
      The effect of zanamivir treatment on the early immune response to influenza vaccination

      VACCINE
    20. Gaillat, J
      An assessment of the antiviral treatment against the flu in 2001

      REVUE DE MEDECINE INTERNE
    21. Gonzales, R; Bartlett, JG; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, JR; Sande, MA
      Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background (reprinted from Annals of Internal Med, March 20, 2001)

      ANNALS OF EMERGENCY MEDICINE
    22. Smee, DF; Sidwell, RW; Morrison, AC; Bailey, KW; Baum, EZ; Ly, L; Wagaman, PC
      Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201

      ANTIVIRAL RESEARCH
    23. Sidwell, RW; Smee, DF; Huffman, JH; Barnard, DL; Morrey, JD; Bailey, KW; Feng, WC; Babu, YS; Bush, K
      Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201

      ANTIVIRAL RESEARCH
    24. Linde, A
      The importance of specific virus diagnosis and monitoring for antiviral treatment

      ANTIVIRAL RESEARCH
    25. Dreitlein, WB; Maratos, J; Brocavich, J
      Zanamivir and oseltamivir: Two new options for the treatment and prevention of influenza

      CLINICAL THERAPEUTICS
    26. Kaiser, L; Fritz, RS; Straus, SE; Gubareva, L; Hayden, FG
      Symptom pathogenesis during acute influenza: Interleukin-6 and other cytokine responses

      JOURNAL OF MEDICAL VIROLOGY
    27. Welliver, R; Monto, AS; Carewicz, O; Schatteman, E; Hassman, M; Hedrick, J; Jackson, HC; Huson, L; Ward, P; Oxford, JS
      Effectiveness of oseltamivir in preventing influenza in household contacts- A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    28. van Elden, LJR; Nijhuis, M; Schipper, P; Schuurman, R; van Loon, AM
      Simultaneous detection of influenza viruses A and B using real-time quantitative PCR

      JOURNAL OF CLINICAL MICROBIOLOGY
    29. Bantia, S; Parker, CD; Ananth, SL; Horn, LL; Andries, K; Chand, P; Kotian, PL; Dehghani, A; El-Kattan, Y; Lin, T; Hutchison, TL; Montgomery, JA; Kellog, DL; Babu, YS
      Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    30. Govorkova, EA; Leneva, IA; Goloubeva, OG; Bush, K; Webster, RG
      Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir againstH5N1, H9N2, and other avian influenza viruses

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    31. Penn, CR; Osterhaus, A
      Zanamivir: A rational approach to influenza B

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    32. Mossad, SB
      Prophylactic and symptomatic: treatment of influenza - Current and developing options

      POSTGRADUATE MEDICINE
    33. Gross, PA
      Vaccines for pneumonia and new antiviral therapies

      MEDICAL CLINICS OF NORTH AMERICA
    34. Guo, CT; Ohta, S; Yoshimoto, A; Nakata, R; Shortridge, KF; Takahashi, T; Suzuki, T; Miyamoto, D; Hidari, KIPJ; Suzuki, Y
      A unique phosphatidylinositol bearing a novel branched-chain fatty acid from Rhodococcus equi binds to influenza virus hemagglutinin and inhibits theinfection of cells

      JOURNAL OF BIOCHEMISTRY
    35. McClellan, K; Perry, CM
      Oseltamivir - A review of its use in influenza

      DRUGS
    36. Oliveira, EC; Marik, PE; Colice, G
      Influenza pneumonia - A descriptive study

      CHEST
    37. Zambon, M; Hays, J; Webster, A; Newman, R; Keene, O
      Diagnosis of influenza in the community - Relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

      ARCHIVES OF INTERNAL MEDICINE
    38. Gonzales, R; Bartlett, JG; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, LR; Sande, MA
      Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background

      ANNALS OF INTERNAL MEDICINE
    39. Peters, PH; Gravenstein, S; Norwood, P; De Bock, V; Van Couter, A; Gibbens, M; von Planta, TA; Ward, P
      Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    40. Duchini, A; Hendry, RM; Redfield, DC; Pockros, PJ
      Influenza infection in patients before and after liver transplantation

      LIVER TRANSPLANTATION
    41. Wiltshire, H; Wiltshire, B; Citron, A; Clarke, T; Serpe, C; Gray, D; Herron, W
      Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasmaand urine

      JOURNAL OF CHROMATOGRAPHY B
    42. Hayden, FG; Jennings, L; Robson, R; Schiff, G; Jackson, H; Rana, B; McClelland, G; Ipe, D; Roberts, N; Ward, P
      Oral oseltamivir in human experimental influenza B infection

      ANTIVIRAL THERAPY
    43. Saito, T; Tashiro, M
      Vaccines and therapeutics against influenza virus infections

      PEDIATRICS INTERNATIONAL
    44. Murphy, KR; Eivindson, A; Pauksens, K; Stein, WJ; Tellier, G; Watts, R; Leophonte, P; Sharp, SJ; Loeschel, E
      Efficacy and safety of inhaled zanamivir for the treatment of influenza inpatients with asthma or chronic obstructive pulmonary disease - A double-blind, randomised, placebo-controlled, multicentre study

      CLINICAL DRUG INVESTIGATION
    45. Safatov, AS; Sergeev, AN; Shishkina, LN; Pyankov, O; Poryvaev, VD; Bulychev, LE; Petrishchenko, VA; Pyankova, OG; Zhukov, VA; Ryzhikov, AB; Boldyrev, AN; Buryak, GA; Raldugin, VA; Kukina, TP; Tolstikov, GA
      Effect of intramuscularly injected polyprenols on influenza virus infection in mice

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    46. Cass, LMR; Gunawardena, KA; Macmahon, MM; Bye, A
      Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir

      RESPIRATORY MEDICINE
    47. Cunney, RJ; Bialachowski, A; Thornley, D; Smaill, FM; Pennie, RA
      An outbreak of influenza A in a neonatal intensive care unit

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    48. Hedrick, JA; Barzilai, A; Behre, U; Henderson, FW; Hammond, J; Reilly, L; Keene, O
      Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    49. Chan, AW; McManus, BM; Ignaszewski, AP
      The enigma of recent onset dilated cardiomyopathy: What cause, what consequence, what control?

      CANADIAN JOURNAL OF CARDIOLOGY
    50. Salzberger, B; Franzen, C; Fatkenheuer, G
      Update in infections diseases. Part II: Diagnosis and therapy

      MEDIZINISCHE KLINIK
    51. Luscher-Mattli, M
      Influenza chemotherapy: a review of the present state of art and of new drugs in development

      ARCHIVES OF VIROLOGY
    52. Sidwell, RW; Smee, DF
      In vitro and in vivo assay systems for study of influenza virus inhibitors

      ANTIVIRAL RESEARCH
    53. de Jong, JC; Rimmelzwaan, GF; Fouchier, RAM; Osterhaus, ADME
      Influenza virus: a master of metamorphosis

      JOURNAL OF INFECTION
    54. Burger, RA; Billingsley, JL; Huffman, JH; Bailey, KW; Kim, CU; Sidwell, RW
      Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice

      IMMUNOPHARMACOLOGY
    55. Monto, AS; Moult, AB; Sharp, SJ
      Effect of zanamivir on duration and resolution of influenza symptoms

      CLINICAL THERAPEUTICS
    56. Nicholson, KG; Aoki, FY; Osterhaus, ADME; Trottier, S; Carewicz, O; Mercier, CH; Rode, A; Kinnersley, N; Ward, P
      Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

      LANCET
    57. Cifu, B; Levinson, W
      Influenza

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    58. Caserta, MT; Hall, CB
      Antiviral agents for influenza

      PEDIATRIC ANNALS
    59. Peng, AW; Milleri, S; Stein, DS
      Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    60. Barnett, JM; Cadman, A; Gor, D; Dempsey, M; Walters, M; Candlin, A; Tisdale, M; Morley, PJ; Owens, IJ; Fenton, RJ; Lewis, AP; Claas, ECJ; Rimmelzwaan, GF; De Groot, R; Osterhaus, ADME
      Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    61. Madero, JGS
      New horizons for the prevention of influenza

      REVISTA DE INVESTIGACION CLINICA
    62. Ruoff, GE
      Zanamivir for the management of influenza

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    63. Peng, AW; Hussey, EK; Rosolowski, B; Blumer, JL
      Pharmacokinetics and tolerability of a single inhaled dose of zanamivir inchildren

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    64. Sun, XL; Sato, N; Kai, T; Furuhata, K
      Novel practical synthesis of Kdn2en and its C-4 nitrogen-modified derivatives

      CARBOHYDRATE RESEARCH
    65. Kaiser, L; Keene, ON; Hammond, JMJ; Elliott, M; Hayden, FG
      Impact of Zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults

      ARCHIVES OF INTERNAL MEDICINE
    66. Monto, AS; Gravenstein, S; Elliott, M; Colopy, M; Schweinle, J
      Clinical signs and symptoms predicting influenza infection

      ARCHIVES OF INTERNAL MEDICINE
    67. Gonzales, R; Sande, MA
      Uncomplicated acute bronchitis

      ANNALS OF INTERNAL MEDICINE
    68. Montalto, NJ; Gum, KD; Ashley, JV
      Updated treatment for influenza A and B

      AMERICAN FAMILY PHYSICIAN
    69. Allen, GD; Brookes, ST; Barrow, A; Dunn, JA; Grosse, CM
      Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum

      JOURNAL OF CHROMATOGRAPHY B
    70. Calfee, DP; Peng, AW; Hussey, EK; Lobo, M; Hayden, FG
      Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection

      ANTIVIRAL THERAPY
    71. Colacino, JM; Staschke, KA; Laver, WG
      Approaches and strategies for the treatment of influenza virus infections

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    72. Sidwelll, RW; Bailey, KW; Bemis, PA; Wong, MH; Eisenberg, EJ; Huffman, JH
      Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    73. Bergstrom, M; Cass, LMR; Valind, S; Westerberg, G; Lundberg, EL; Gray, S; Bye, A; Langstrom, B
      Deposition and disposition of [C-11]zanamivir following administration as an intranasal spray - Evaluation with positron emission tomography

      CLINICAL PHARMACOKINETICS
    74. Colman, PM
      A novel approach to antiviral therapy for influenza

      Journal of antimicrobial chemotherapy
    75. Treanor, J; Falsey, A
      Respiratory viral infections in the elderly

      ANTIVIRAL RESEARCH
    76. Calfee, DP; Peng, AW; Cass, LM; Lobo, M; Hayden, FG
      Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    77. Fenton, RJ; Morley, PJ; Owens, IJ; Gower, D; Parry, S; Crossman, L; Wong, T
      Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    78. Barnett, JM; Cadman, A; Burrell, FM; Madar, SH; Lewis, AP; Tisdale, M; Bethell, R
      In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

      VIROLOGY
    79. Rowley, KV; Harvey, R; Barclay, WS
      Isolation and characterization of a transfectant influenza B virus alteredin RNA segment 6

      JOURNAL OF GENERAL VIROLOGY
    80. Ruf, BR; Kern, WV
      Infectious diseases

      INTERNIST
    81. Bardsley-Elliot, A; Noble, S
      Oseltamivir

      DRUGS
    82. EISENBERG EJ; CUNDY KC
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GS4071, A POTENT INHIBITOR OF INFLUENZA NEURAMINIDASE, IN PLASMA BY PRECOLUMN FLUORESCENCE DERIVATIZATION WITH NAPHTHALENEDIALDEHYDE

      Journal of chromatography B. Biomedical sciences and applications
    83. OLIYAI R; YUAN LC; DAHL TC; SWAMINATHAN S; WANG KY; LEE WA
      BIEXPONENTIAL DECOMPOSITION OF A NEURAMINIDASE INHIBITOR PRODRUG (GS-4104) IN AQUEOUS-SOLUTION

      Pharmaceutical research
    84. SIDWELL RW; HUFFMAN JH; BARNARD DL; BAILEY KW; WONG MH; MORRISON A; SYNDERGAARD T; KIM CU
      INHIBITION OF INFLUENZA-VIRUS INFECTIONS IN MICE BY GS4104, AN ORALLYEFFECTIVE INFLUENZA-VIRUS NEURAMINIDASE INHIBITOR

      Antiviral research
    85. MAIONE AM; GIORDANI E; COSTA M; SPIRITO A
      CARBOHYDRATE NATURAL-PRODUCTS AS A SCAFFOLDING FOR THE PREPARATION OFPOTENTIAL NEURAMINIDASE INHIBITORS

      Archiv der pharmazie
    86. MADREN LK; SHIPMAN C; HAYDEN FG
      IN-VITRO INHIBITORY EFFECTS OF COMBINATIONS OF ANTIINFLUENZA AGENTS

      Antiviral chemistry & chemotherapy
    87. MORRIS DM; HUSSEY BK; GEURIN SL; SELINGER KA
      DETERMINATION OF THE NOVEL SIALIC-ACID ANALOG GG167 (GR121167X) IN HUMAN URINE BY LIQUID-CHROMATOGRAPHY - DIRECT-INJECTION WITH COLUMN-SWITCHING

      Journal of pharmaceutical and biomedical analysis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 17:01:19